ArticleThe World Allergy Organization journal2020

Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous rrticaria - A real-life experience.

Ramit Maoz-Segal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.